Vimarsana
Biggest News Aggregation in the World

Andrew Ip News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andrew Ip. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andrew Ip Today - Breaking & Trending Today

Dr Ip on the Implications of NGS Plus Machine Learning for Diagnosing Hematologic Malignancies - Vimarsana News

Dr Ip on the Implications of NGS Plus Machine Learning for Diagnosing Hematologic Malignancies

Andrew Ip, MD, discusses the implications of using next-generation sequencing alongside machine learning in the diagnosis of hematologic malignancies.

Dr Ip on the Importance of NGS Testing in Hematologic Malignancies - Vimarsana News

Dr Ip on the Importance of NGS Testing in Hematologic Malignancies

Andrew Ip, MD, discusses findings from a study on the use of next-generation sequencing of flow cytometry CD markers and machine learning as a replacement to flow cytometry analysis for the diagnosis of hematologic neoplasms.

John Theurer Cancer Center Investigators Present Pioneering Research at the American Society of Hematology Annual Conference - Vimarsana News

John Theurer Cancer Center Investigators Present Pioneering Research at the American Society of Hematology Annual Conference

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Falcon V Systems, Charter and Liberty Global to develop open DAA for multi-vendor environment - Vimarsana News

Falcon V Systems, Charter and Liberty Global to develop open DAA for multi-vendor environment

New partnership will accelerate the delivery of key virtualization technologies, including Falcon V Systems' MAC Manager for Open DAA, which will increase the velocity and lower the total cost of network deployments.

New model can help clinicians to predict 40-day mortality risk in hospitalized COVID-19 patients - Vimarsana News

New model can help clinicians to predict 40-day mortality risk in hospitalized COVID-19 patients

New model can help clinicians to predict 40-day mortality risk in hospitalized COVID-19 patients Researchers from Hackensack Meridian University Medical Center and Berry Consultants, LLC, Austin, Texas have developed a new model to help clinicians predict the risk of death within 40 days in patients who are hospitalized with COVID-19 infection. A new paper describing this retrospective, observational, multicenter cohort analysis, "Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19," was recently published in PLOS ONE, a peer-revie...